Researchers Say Blood Test For Gastric Cancer-Related microRNA May Be Cost-Effective And Could Greatly Increase Early Diagnoses
September 28, 2020
The Journal of Clinical Pathways (9/25, Tumolo) reports researchers found “an intervention involving a blood test for gastric cancer–related microRNA in a population at intermediate risk is cost-effective and could as much as double cancer diagnoses in ea...